The Patent Finder

Santaris Pharma A/S

Also on record
Records under this name other than patents Santaris Pharma A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Santaris Pharma A/S

PatentTitleStatus Expires Confidence
US 9,133,455Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,653,252Short interfering RNA (siRNA) analogues
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,045,518Amino-LNA, thio-LNA and alpha-L-oxy-LN
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,790,493MICROMIRs
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,450,564Micromirs
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,288,356MicroRNAs
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,563,528Antisense oligomers targeting PCSK9
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,906,871MicromiRs
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,358,643Poly Oligomer Compound with Biocleavable Conjugates
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,785,834Soluble TNF receptors and their use in treatment of disease
Formerly held
In force
Term ended Nov 10, 2026 · From the USPTO record
In forceTerm ended Nov 10, 2026From the USPTO record
10 of 67 patents shown.
Pro members see all 67.
Pro members: see all 67 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited